Cargando…
Abobotulinum - a toxin injection in patients with refractory idiopathic detrusor overactivity: injections in detrusor, trigone and bladder neck or prostatic urethra, versus detrusor - only injections
PURPOSE: To evaluate if the injections of abobotulinum-A toxin in trigone and bladder neck/prostatic urethra in addition to detrusor provides better symptoms relief and urodynamic findings in patients with idiopathic detrusor overactivity (IDO) refractory to medical treatment. MATERIALS AND METHODS:...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Urologia
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5734076/ https://www.ncbi.nlm.nih.gov/pubmed/28727385 http://dx.doi.org/10.1590/S1677-5538.IBJU.2016.0622 |
_version_ | 1783286996308852736 |
---|---|
author | Emami, Maryam Shadpour, Pejman Kashi, Amir H. Choopani, Masoud Zeighami, Mohammadreza |
author_facet | Emami, Maryam Shadpour, Pejman Kashi, Amir H. Choopani, Masoud Zeighami, Mohammadreza |
author_sort | Emami, Maryam |
collection | PubMed |
description | PURPOSE: To evaluate if the injections of abobotulinum-A toxin in trigone and bladder neck/prostatic urethra in addition to detrusor provides better symptoms relief and urodynamic findings in patients with idiopathic detrusor overactivity (IDO) refractory to medical treatment. MATERIALS AND METHODS: A total of 74 patients with IDO refractory to anticholinergics received injections in detrusor, trigone and bladder neck/prostatic urethra (Group A, N=36) versus detrusor only injections (Group B, N=38) of abobotulinum-A toxin. All patients were evaluated by a standard overactive bladder symptom score (OABSS) questionnaire and cystometrography before and 6 weeks after the operation. OABSS questionnaire was also completed 20 weeks after the operation. RESULTS: The magnitude of OABSS reduction from baseline to 6 weeks after operation in groups A and B patients was 13.4±2.2 versus 11.7±2.1 (p=0.001). Cystometry results were similar in both groups except for higher volume at urgent desire to void in Group B patients (p <0.001). The mean±SD change in residual volume in Group A at 6 weeks after the operation was −4.8±28.6mL (p=0.33) compared to 21.3±16.9mL in Group B patients (p <0.001). CONCLUSIONS: In patients with IDO, adding trigone, and bladder neck/prostatic urethra as sites of abobotulinum- A toxin injection produces greater reductions in OABSS score and less residual urine volume but a lower volume at urgent desire to void in comparison with detrusor only injections. |
format | Online Article Text |
id | pubmed-5734076 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Sociedade Brasileira de Urologia |
record_format | MEDLINE/PubMed |
spelling | pubmed-57340762017-12-19 Abobotulinum - a toxin injection in patients with refractory idiopathic detrusor overactivity: injections in detrusor, trigone and bladder neck or prostatic urethra, versus detrusor - only injections Emami, Maryam Shadpour, Pejman Kashi, Amir H. Choopani, Masoud Zeighami, Mohammadreza Int Braz J Urol Original Article PURPOSE: To evaluate if the injections of abobotulinum-A toxin in trigone and bladder neck/prostatic urethra in addition to detrusor provides better symptoms relief and urodynamic findings in patients with idiopathic detrusor overactivity (IDO) refractory to medical treatment. MATERIALS AND METHODS: A total of 74 patients with IDO refractory to anticholinergics received injections in detrusor, trigone and bladder neck/prostatic urethra (Group A, N=36) versus detrusor only injections (Group B, N=38) of abobotulinum-A toxin. All patients were evaluated by a standard overactive bladder symptom score (OABSS) questionnaire and cystometrography before and 6 weeks after the operation. OABSS questionnaire was also completed 20 weeks after the operation. RESULTS: The magnitude of OABSS reduction from baseline to 6 weeks after operation in groups A and B patients was 13.4±2.2 versus 11.7±2.1 (p=0.001). Cystometry results were similar in both groups except for higher volume at urgent desire to void in Group B patients (p <0.001). The mean±SD change in residual volume in Group A at 6 weeks after the operation was −4.8±28.6mL (p=0.33) compared to 21.3±16.9mL in Group B patients (p <0.001). CONCLUSIONS: In patients with IDO, adding trigone, and bladder neck/prostatic urethra as sites of abobotulinum- A toxin injection produces greater reductions in OABSS score and less residual urine volume but a lower volume at urgent desire to void in comparison with detrusor only injections. Sociedade Brasileira de Urologia 2017 /pmc/articles/PMC5734076/ /pubmed/28727385 http://dx.doi.org/10.1590/S1677-5538.IBJU.2016.0622 Text en https://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Emami, Maryam Shadpour, Pejman Kashi, Amir H. Choopani, Masoud Zeighami, Mohammadreza Abobotulinum - a toxin injection in patients with refractory idiopathic detrusor overactivity: injections in detrusor, trigone and bladder neck or prostatic urethra, versus detrusor - only injections |
title | Abobotulinum - a toxin injection in patients with refractory idiopathic detrusor overactivity: injections in detrusor, trigone and bladder neck or prostatic urethra, versus detrusor - only injections |
title_full | Abobotulinum - a toxin injection in patients with refractory idiopathic detrusor overactivity: injections in detrusor, trigone and bladder neck or prostatic urethra, versus detrusor - only injections |
title_fullStr | Abobotulinum - a toxin injection in patients with refractory idiopathic detrusor overactivity: injections in detrusor, trigone and bladder neck or prostatic urethra, versus detrusor - only injections |
title_full_unstemmed | Abobotulinum - a toxin injection in patients with refractory idiopathic detrusor overactivity: injections in detrusor, trigone and bladder neck or prostatic urethra, versus detrusor - only injections |
title_short | Abobotulinum - a toxin injection in patients with refractory idiopathic detrusor overactivity: injections in detrusor, trigone and bladder neck or prostatic urethra, versus detrusor - only injections |
title_sort | abobotulinum - a toxin injection in patients with refractory idiopathic detrusor overactivity: injections in detrusor, trigone and bladder neck or prostatic urethra, versus detrusor - only injections |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5734076/ https://www.ncbi.nlm.nih.gov/pubmed/28727385 http://dx.doi.org/10.1590/S1677-5538.IBJU.2016.0622 |
work_keys_str_mv | AT emamimaryam abobotulinumatoxininjectioninpatientswithrefractoryidiopathicdetrusoroveractivityinjectionsindetrusortrigoneandbladderneckorprostaticurethraversusdetrusoronlyinjections AT shadpourpejman abobotulinumatoxininjectioninpatientswithrefractoryidiopathicdetrusoroveractivityinjectionsindetrusortrigoneandbladderneckorprostaticurethraversusdetrusoronlyinjections AT kashiamirh abobotulinumatoxininjectioninpatientswithrefractoryidiopathicdetrusoroveractivityinjectionsindetrusortrigoneandbladderneckorprostaticurethraversusdetrusoronlyinjections AT choopanimasoud abobotulinumatoxininjectioninpatientswithrefractoryidiopathicdetrusoroveractivityinjectionsindetrusortrigoneandbladderneckorprostaticurethraversusdetrusoronlyinjections AT zeighamimohammadreza abobotulinumatoxininjectioninpatientswithrefractoryidiopathicdetrusoroveractivityinjectionsindetrusortrigoneandbladderneckorprostaticurethraversusdetrusoronlyinjections |